Detalhe da pesquisa
1.
Discovery of Vixotrigine: A Novel Use-Dependent Sodium Channel Blocker for the Treatment of Trigeminal Neuralgia.
ACS Med Chem Lett
; 11(9): 1678-1687, 2020 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32945812
2.
Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial.
Lancet Neurol
; 16(4): 291-300, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28216232
3.
Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia.
Trials
; 14: 402, 2013 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24267010